Publication | Open Access
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias
204
Citations
27
References
2011
Year
This crossover study provides Class II evidence that 4AP decreases attack frequency and improves the patient-reported quality of life in patients with episodic ataxia and related familial ataxias.
| Year | Citations | |
|---|---|---|
Page 1
Page 1